JP

John Prendergast

Recce Pharmaceuticals Ltd | Non-Executive Director, Non-Executive Chairman
Dr Prendergast is an executive in the pharmaceutical industry. Currently serving as the Chairman and Co-founder of Palatin Technologies, Inc. and the Lead Director of Nighthawk Biosciences (NYSE: HHWK), he brings over three decades of experience in the commercialisation of pharmaceutical technologies. He is a member of Risk Committee.

Company and Roles

Company
Title
Tenure
Since
RCE
RCE
Recce Pharmaceuticals Ltd
  • Non-Executive Director
  • Non-Executive Chairman
6yrs, 7mthApr 2018

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RCE
RCE
Recce Pharmaceuticals Ltd
30/06/24306,819N/A2,175,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RCE
RCE
Recce Pharmaceuticals Ltd
07/12/23
Issued
56,819$0.440$25,000Rights issue
RCE
RCE
Recce Pharmaceuticals Ltd
22/02/21
Issued
2,175,000$1.030$2,240,250Issue of options
RCE
RCE
Recce Pharmaceuticals Ltd
15/02/19
Issued
250,000$0.155$38,750Director remuneration.